Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q2- Text added to 2015 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
accretion, Agila, alfa, Amneal, assembled, attention, Aurangabad, Austrian, autoimmune, Ben, broadened, capture, Celltrion, Chase, Coalition, Colorectal, composition, confirming, consummation, criteria, decree, deposit, Depository, disruption, Dr, EEA, efficient, element, emphasize, endocrine, epoetin, Epogen, escrow, Eurohealth, forma, frame, friendly, furniture, Green, hearing, Hikma, home, HR, hyperactivity, immaterial, indenture, Inflectra, infliximab, injunctive, installed, instance, Inter, Irungattukottai, IX, Johnson, JPMorgan, Kabi, labor, land, leased, legacy, lodged, machinery, Maharashtra, Manhattan, Mellon, momentum, month, MPCB, NGT, Orion, overcoming, owner, pill, policy, Pollution, Precedex, preliminary, premise, premix, presidential, pro, Procrit, provisional, PTAB, raw, Reddy, Remsima, respond, restoration, Retacrit, rituximab, Sarl, satisfaction, scrutiny, season, slight, slowdown, soil, stand, statutory, tigecycline, trastuzumab, Tribunal, TV, unapproved, unidentified, upcoming, USPTO, valuation, Venue, viable, vicinity, willfully, worth, wrote
Removed:
customary, franc, mature, weakening
Valuein 2015 Q2 filing- Value in 2015 Q3 filing
Original filings
Filing view